IN164030B - - Google Patents

Info

Publication number
IN164030B
IN164030B IN746/MAS/86A IN746MA1986A IN164030B IN 164030 B IN164030 B IN 164030B IN 746MA1986 A IN746MA1986 A IN 746MA1986A IN 164030 B IN164030 B IN 164030B
Authority
IN
India
Prior art keywords
biphenylyl
fluoro
analgesic
propionic acid
rapid
Prior art date
Application number
IN746/MAS/86A
Other languages
English (en)
Inventor
Smith Alan
Bird Graham
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of IN164030B publication Critical patent/IN164030B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
IN746/MAS/86A 1985-10-03 1986-09-23 IN164030B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858524421A GB8524421D0 (en) 1985-10-03 1985-10-03 Therapeutic agents

Publications (1)

Publication Number Publication Date
IN164030B true IN164030B (pt) 1988-12-31

Family

ID=10586136

Family Applications (1)

Application Number Title Priority Date Filing Date
IN746/MAS/86A IN164030B (pt) 1985-10-03 1986-09-23

Country Status (22)

Country Link
US (1) US4786495A (pt)
EP (1) EP0223369B1 (pt)
JP (1) JPS62111922A (pt)
KR (1) KR940000231B1 (pt)
AT (1) ATE59291T1 (pt)
AU (1) AU594264B2 (pt)
CA (1) CA1275930C (pt)
CS (1) CS271463B2 (pt)
DE (1) DE3676645D1 (pt)
DK (1) DK165165C (pt)
EG (1) EG17609A (pt)
ES (1) ES2033682T3 (pt)
FI (1) FI84314C (pt)
GB (1) GB8524421D0 (pt)
GR (1) GR3001312T3 (pt)
IE (1) IE59134B1 (pt)
IN (1) IN164030B (pt)
NO (1) NO173046C (pt)
NZ (1) NZ217703A (pt)
PT (1) PT83474B (pt)
RU (1) RU1800996C (pt)
ZA (1) ZA867309B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
GB8701392D0 (en) * 1987-01-22 1987-02-25 Boots Co Plc Therapeutic agents
US5240712A (en) * 1987-07-17 1993-08-31 The Boots Company Plc Therapeutic agents
US5286751A (en) * 1987-12-24 1994-02-15 Analgesic Associates Sustained/enhanced antipyretic response
US4980175A (en) * 1989-01-03 1990-12-25 Leonard Chavkin Liquid orally administrable compositions based on edible oils
US5189066A (en) * 1989-11-22 1993-02-23 The Procter & Gamble Company Pharmaceutical compositions of tebufelone
US5681964A (en) * 1990-10-23 1997-10-28 University Of Kentucky Research Foundation Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140184C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140172C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Ibuprofen enthaltendes Arzneimittel
US5281420A (en) * 1992-05-19 1994-01-25 The Procter & Gamble Company Solid dispersion compositions of tebufelone
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
GB9325445D0 (en) * 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5545628A (en) † 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate
JP2001520984A (ja) * 1997-10-27 2001-11-06 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 水難溶性薬剤の固態溶剤及び固体分散体
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
FR2775597B1 (fr) * 1998-03-04 2001-04-20 Gattefosse Ets Sa Pellet administrable par voie orale apte a ameliorer la biodisponibilite de la substance active, procede de fabrication
US6765019B1 (en) * 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
ITMI20011338A1 (it) * 2001-06-26 2002-12-26 Farmatron Ltd Composizioni farmaceutiche orali a rilascio immediato del principio attivo
DK1521572T3 (da) * 2002-07-15 2009-05-04 Alcon Inc Biologisk nedbrydelig film til indförsel af öjenlægemiddel
US7678827B2 (en) * 2002-07-15 2010-03-16 Alcon, Inc. Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
AU2003280960A1 (en) * 2002-07-15 2004-02-02 Alcon, Inc. Pharmaceutical compositions for otic use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274354A (fr) * 1956-03-10 1961-10-27 Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
US3966978A (en) * 1975-04-25 1976-06-29 American Cyanamid Company 4-Biphenylacetic acid as an inhibitor of platelet aggregation
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
JPS57171912A (en) * 1981-04-14 1982-10-22 Sumitomo Chem Co Ltd Cream
JPS5913720A (ja) * 1982-07-15 1984-01-24 Green Cross Corp:The フルルビプロフエン脂肪乳剤
US4477468A (en) * 1982-12-06 1984-10-16 The Upjohn Company Treatment of type II herpes virus with flurbiprofen
IT1170238B (it) * 1982-12-06 1987-06-03 Upjohn Co Impiego di ibuprofene e flurbiprofene nella cura dell'erpete
US4473584A (en) * 1982-12-06 1984-09-25 The Upjohn Company Treatment of Type I Herpes virus with flurbiprofen
JPS59122425A (ja) * 1982-12-27 1984-07-14 Kaken Pharmaceut Co Ltd 持続性製剤およびその製造法
JPS601122A (ja) * 1983-06-20 1985-01-07 Green Cross Corp:The ビフエニリルプロピオン酸誘導体脂肪乳剤
US4543251A (en) * 1983-12-09 1985-09-24 Toko Yakuhin Industry Co., Ltd. Gel preparations for external application
IT1191608B (it) * 1985-02-01 1988-03-23 Zambon Spa Composizione farmaceutica e forme farmaceutiche che la contengono
EP0212747B1 (en) * 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release and immediate release
EP0275526A3 (en) * 1986-12-27 1990-01-31 Banyu Pharmaceutical Co., Ltd. Composition for administration through a body cavity

Also Published As

Publication number Publication date
AU6346586A (en) 1987-04-09
JPS62111922A (ja) 1987-05-22
JPH0428243B2 (pt) 1992-05-13
EP0223369A3 (en) 1987-12-02
NO173046C (no) 1993-10-20
IE59134B1 (en) 1994-01-12
EP0223369B1 (en) 1990-12-27
ES2033682T3 (es) 1993-04-01
PT83474B (pt) 1989-02-28
US4786495A (en) 1988-11-22
NO173046B (no) 1993-07-12
CS708386A2 (en) 1990-02-12
DK165165C (da) 1993-03-01
GB8524421D0 (en) 1985-11-06
CA1275930C (en) 1990-11-06
DE3676645D1 (de) 1991-02-07
DK165165B (da) 1992-10-19
NZ217703A (en) 1989-01-06
CS271463B2 (en) 1990-10-12
GR3001312T3 (en) 1992-08-31
ZA867309B (en) 1987-05-27
FI863976A (fi) 1987-04-04
KR940000231B1 (ko) 1994-01-12
EG17609A (en) 1995-04-30
IE862449L (en) 1987-04-03
FI863976A0 (fi) 1986-10-01
AU594264B2 (en) 1990-03-01
FI84314C (fi) 1991-11-25
FI84314B (fi) 1991-08-15
RU1800996C (ru) 1993-03-07
NO863935L (no) 1987-04-06
DK453386A (da) 1987-04-04
EP0223369A2 (en) 1987-05-27
NO863935D0 (no) 1986-10-02
DK453386D0 (da) 1986-09-23
ATE59291T1 (de) 1991-01-15
KR870003772A (ko) 1987-05-04
PT83474A (en) 1986-11-01

Similar Documents

Publication Publication Date Title
IN164030B (pt)
DE60000133D1 (de) Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen
YU89891A (sh) SMEŠE TGF-beta
GB8819110D0 (en) Antihypertensive drug & method for production
ES2031822T3 (es) Un procedimiento para preparar una composicion farmaceutica con propiedades inhibidoras de la renina.
CA2004332A1 (en) Inhibition of cell adhesion
HUP9903855A2 (hu) Orális adagolásra való valproesavat tartalmazó gyógyszerészeti mikrogömbök
IL90056A0 (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
AU2072088A (en) Agent containing salicylic acid for treating lepidosis
JPS5791913A (en) Pharmaceutical preparation of drug
HUT51105A (en) Pesticide comprising substituted acrylic acid ester derivatives as active ingredient and process for producing the active ingredients
ES8205190A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10-14-hexadecapentaenoico.
PH21875A (en) Novel carboxylic acid esters,their method of use and insecticides containing them as the active ingredient
GR861147B (en) Haloalkoxy anilide derivatives of 2-(4-heterocyclic oxyphenoxy)-alkanoic acids and their use as herbicides
ES8308827A1 (es) Un procedimiento para la preparacion de nuevos derivados poliprenilicos.
EP0420056A3 (en) Use of fatty acids, fatty acid salts and fatty acid esters of mono-, di- or trihydroxy alkanes or their derivatives
SE8304331D0 (sv) Arzneimittel mit analgetischer wirkung
JPS56128731A (en) Ester of arylpropionic acid, manufacture and medicine of effective ingredient
JPS56131545A (en) Ester of arylpropionic acid, its manufacture and medicine of its effective component
IT1270699B (it) Sali dell'acido s(+)-2-(4-isobutilfenil)propionico con mono-, di- e trialcanolammine
IT1227158B (it) Esteri dell'acido tiamorfolinone carbossilico e di suoi derivati, loro procedimento di preparazione e loro impiego nel settore cosmetico e nel settore dermo farmaceutico.
GB9218065D0 (en) Method for the safe administration of fatty acids and their lithium salts
GB9217712D0 (en) Method for the safe administration of fatty acids and their lithium salts